Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 12

1.

Bridging the gap between education and appropriate use of benzodiazepines in psychiatric clinical practice.

Dell'Osso B, Albert U, Atti AR, Carmassi C, Carrà G, Cosci F, Del Vecchio V, Di Nicola M, Ferrari S, Goracci A, Iasevoli F, Luciano M, Martinotti G, Nanni MG, Nivoli A, Pinna F, Poloni N, Pompili M, Sampogna G, Tarricone I, Tosato S, Volpe U, Fiorillo A.

Neuropsychiatr Dis Treat. 2015 Jul 30;11:1885-909. doi: 10.2147/NDT.S83130. eCollection 2015. Review.

2.

Impact of alprazolam in allostatic load and neurocognition of patients with anxiety disorders and chronic stress (GEMA): observational study protocol.

Soria CA, Remedi C, Núñez DA, D'Alessio L, Roldán EJ.

BMJ Open. 2015 Jul 14;5(7):e007231. doi: 10.1136/bmjopen-2014-007231. Erratum in: BMJ Open. 2015;5(8):e007231.

3.

Benzodiazepine Use and Cognitive Decline in Elderly With Normal Cognition.

Zhang Y, Zhou XH, Meranus DH, Wang L, Kukull WA.

Alzheimer Dis Assoc Disord. 2016 Apr-Jun;30(2):113-7. doi: 10.1097/WAD.0000000000000099.

4.

Association between Benzodiazepine Use and Dementia: A Meta-Analysis.

Zhong G, Wang Y, Zhang Y, Zhao Y.

PLoS One. 2015 May 27;10(5):e0127836. doi: 10.1371/journal.pone.0127836. eCollection 2015.

5.

Benzodiazepine use and risk of Alzheimer's disease: case-control study.

Billioti de Gage S, Moride Y, Ducruet T, Kurth T, Verdoux H, Tournier M, Pariente A, Bégaud B.

BMJ. 2014 Sep 9;349:g5205. doi: 10.1136/bmj.g5205.

6.

Risk of dementia in patients with insomnia and long-term use of hypnotics: a population-based retrospective cohort study.

Chen PL, Lee WJ, Sun WZ, Oyang YJ, Fuh JL.

PLoS One. 2012;7(11):e49113. doi: 10.1371/journal.pone.0049113. Epub 2012 Nov 7.

7.

Benzodiazepine use and risk of dementia: prospective population based study.

Billioti de Gage S, Bégaud B, Bazin F, Verdoux H, Dartigues JF, Pérès K, Kurth T, Pariente A.

BMJ. 2012 Sep 27;345:e6231. doi: 10.1136/bmj.e6231.

8.

Use of CNS medications and cognitive decline in the aged: a longitudinal population-based study.

Puustinen J, Nurminen J, Löppönen M, Vahlberg T, Isoaho R, Räihä I, Kivelä SL.

BMC Geriatr. 2011 Nov 1;11:70. doi: 10.1186/1471-2318-11-70.

9.

The amyloid beta ion channel hypothesis of Alzheimer's disease.

Shirwany NA, Payette D, Xie J, Guo Q.

Neuropsychiatr Dis Treat. 2007;3(5):597-612.

10.

An immunohistochemical study of GABA A receptor gamma subunits in Alzheimer's disease hippocampus: relationship to neurofibrillary tangle progression.

Iwakiri M, Mizukami K, Ikonomovic MD, Ishikawa M, Abrahamson EE, DeKosky ST, Asada T.

Neuropathology. 2009 Jun;29(3):263-9. doi: 10.1111/j.1440-1789.2008.00978.x. Epub 2008 Nov 19.

11.

The role of beta-amyloid protein in synaptic function: implications for Alzheimer's disease therapy.

Peña F, Gutiérrez-Lerma A, Quiroz-Baez R, Arias C.

Curr Neuropharmacol. 2006 Apr;4(2):149-63.

Supplemental Content

Support Center